Literature DB >> 25672318

Clinical and demographic profile of chromoblastomycosis in a referral service in the midwest of São Paulo state (Brazil).

Gabriela Franco Marques1, Paula Yoshiko Masuda1, Juliana Martins Prazeres Sousa1, Jaison Antônio Barreto1, Patrick Alexander Wachholz2.   

Abstract

Chromoblastomycosis is one of the most frequent deep mycoses found in rural populations. This cross-sectional, retrospective and descriptive study was conducted with cases of chromoblastomycosis diagnosed throughout 20 years. A higher prevalence was observed among White male rural workers, with an average age of 59.69 years. Median time between onset of symptoms and diagnosis was 156 months. Lesions were predominantly located on the lower limbs; 34% of cases reported previous trauma. The most common associated symptoms were itching, pain and burning sensation. Mycological examination was positive in 91% of cases and Fonsecaea pedrosoi was the most prevalent etiologic agent.

Entities:  

Mesh:

Year:  2015        PMID: 25672318      PMCID: PMC4323717          DOI: 10.1590/abd1806-4841.20153252

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  9 in total

1.  Chromoblastomycosis.

Authors:  Edoardo Torres-Guerrero; Rafael Isa-Isa; Mariel Isa; Roberto Arenas
Journal:  Clin Dermatol       Date:  2012 Jul-Aug       Impact factor: 3.541

Review 2.  Chromoblastomycosis.

Authors:  Rubén López Martínez; Luis Javier Méndez Tovar
Journal:  Clin Dermatol       Date:  2007 Mar-Apr       Impact factor: 3.541

3.  Chromoblastomycosis: a clinical and molecular study of 18 cases in Rio de Janeiro, Brazil.

Authors:  Marcelle de F Mouchalouat; Maria Clara Gutierrez Galhardo; Rosely Maria Zancopé-Oliveira; Paulo Cezar Monteiro Fialho; Janice Mery C de Oliveira Coelho; Patrícia Morais Silva Tavares; Antonio Carlos Francesconi do Valle
Journal:  Int J Dermatol       Date:  2011-08       Impact factor: 2.736

4.  Clinical, epidemiological and mycological report on 65 patients from the Eastern Amazon region with chromoblastomycosis.

Authors:  Carla Andréa Avelar Pires; Marilia Brasil Xavier; Juarez Antônio Simões Quaresma; Geraldo Mariano Moraes de Macedo; Bruna Ranyelle de Marinho Sousa; Arival Cardoso de Brito
Journal:  An Bras Dermatol       Date:  2012 Jul-Aug       Impact factor: 1.896

Review 5.  Chromoblastomycosis: study of 27 cases and review of medical literature.

Authors:  Rafaela Teixeira Marinho Correia; Neusa Y S Valente; Paulo Ricardo Criado; José Eduardo da Costa Martins
Journal:  An Bras Dermatol       Date:  2010 Jul-Aug       Impact factor: 1.896

6.  Chromoblastomycosis in Kerala, India.

Authors:  Veena Chandran; Sadeep M Sadanandan; K Sobhanakumari
Journal:  Indian J Dermatol Venereol Leprol       Date:  2012 Nov-Dec       Impact factor: 2.545

Review 7.  Chromoblastomycosis: clinical presentation and management.

Authors:  M Ameen
Journal:  Clin Exp Dermatol       Date:  2009-07-02       Impact factor: 3.470

Review 8.  Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.

Authors:  Flavio Queiroz-Telles; Phillippe Esterre; Maigualida Perez-Blanco; Roxana G Vitale; Claudio Guedes Salgado; Alexandro Bonifaz
Journal:  Med Mycol       Date:  2008-12-09       Impact factor: 4.076

9.  Revisiting the clinical and histopathological aspects of patients with chromoblastomycosis from the Brazilian Amazon region.

Authors:  Carla Avelar-Pires; Juarez Antonio Simoes-Quaresma; Geraldo Mariano Moraes-de Macedo; Marilia Brasil-Xavier; Arival Cardoso-de Brito
Journal:  Arch Med Res       Date:  2013-05-14       Impact factor: 2.235

  9 in total
  5 in total

1.  Chromoblastomycosis: tissue modifications during itraconazole treatment.

Authors:  Kátia Sheylla Malta Purim; Murilo Calvo Peretti; José Fillus; Marcia Olandoski
Journal:  An Bras Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.896

2.  Tumoral chromoblastomycosis: a rare manifestation with typical complementary exams.

Authors:  John Verrinder Veasey; Beatriz de Abreu Ribeiro Machado; Rute Facchini Lellis; Laura Hitomi Muramatu; Clarisse Zaitz
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

3.  Final diagnosis of 86 cases included in differential diagnosis of American tegumentary leishmaniasis in a Brazilian sample: a retrospective cross-sectional study.

Authors:  Fernanda Tirelli; Sebastian Vernal; Ana Maria Roselino
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

4.  New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole.

Authors:  Rowena Alves Coelho; Gabriela Machado Alves; Maria Helena Galdino Figueiredo-Carvalho; Fernando Almeida-Silva; Gabriela Rodrigues de Souza; Maria Cristina da Silva Lourenço; Fábio Brito-Santos; Ana Claudia Fernandes Amaral; Rodrigo Almeida-Paes
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-09-12       Impact factor: 2.747

5.  Chromoblastomycosis: A case series from Eastern China.

Authors:  Sujun Liu; Huilin Zhi; Hong Shen; Wenwen Lv; Bo Sang; Qiuping Li; Yan Zhong; Zehu Liu; Xiujiao Xia
Journal:  PLoS Negl Trop Dis       Date:  2022-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.